Chernivtsi Regional Clinical Oncology Center

Chernivtsi 58013

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Endometrial Cancer, Small Cell Lung Cancer

Studies at this site

• Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC — Completed
• SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma — Completed
• Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer — Completed